Is mental retardation a defect of synapse structure and function?

Pediatric Neurology

Volumn 29, Issue 1, 2003, Pages 11-17

  Chechlacz, Magdalena ^a   Gleeson, Joseph G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; GUANINE DISSOCIATION INHIBITOR 1; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; OLIGOPHRENIN 1; P21 ACTIVATED KINASE; PROTEIN DERIVATIVE; PROTEIN KINASE; RHO FACTOR; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; UNCLASSIFIED DRUG;

ACTIN FILAMENT; CELL STRUCTURE; CELL TRANSPORT; COGNITION; COGNITIVE DEFECT; CYTOSKELETON; DENDRITE; DENDRITIC SPINE; DEVELOPMENTAL DISORDER; DOWN SYNDROME; FETAL ALCOHOL SYNDROME; FILOPODIUM; FRAGILE X SYNDROME; GENE FUNCTION; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; HUMAN; LAMELLIPODIUM; MENTAL DEFICIENCY; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE FUNCTION; NERVE LESION; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATAU SYNDROME; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RETT SYNDROME; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPSE VESICLE; X CHROMOSOME LINKAGE;

EID: 0141455375     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(03)00152-8     Document Type: Review

References (69)

1. Penrose LS. A clinical and genetic study of 1280 cases of mental defects (The Colchester Survey). Special report series, Medical Research Council No. 229, Her Majesty's Stationary Office, London, 1938.
2. Imbert G., Feng Y., Nelson D., et al. Clinical and diagnostic aspects of fragile X syndrome. Wells R.D., Warren S.T. Genetic instabilities and hereditary neurological diseases. 1998;27-53 Academic Press, San Diego.
3. Stevenson RE, Schwartz CE, Schroer RJ. Emergence of the concept of X-linked mental retardation. In: Stevenson RE, Schwartz CE, Schroer RJ, editors. X-Linked mental retardation. New York: Oxford University Press, 2000:23-67.
4. Gedeon A.K., Donnelly A.J., Mulley J.C., et al. How many X-linked genes for non-specific mental retardation (MRX) are there? Am J Med Genet. 64:1996;158-162.
5. Allison D.W., Gelfand V.I., Spector I., et al. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons Differential attachment of NMDA versus AMPA receptors . J Neurosci. 18:1998;2423-2436.
6. Wyszynski M., Kharazia V., Shanghvi R., et al. Differential regional expression and ultrastructural localization of alpha-actinin-2, a putative NMDA receptor-anchoring protein, in rat brain. J Neurosci. 18:1998;1383-1392.
7. Tanaka E., Sabry J. Making the connection Cytoskeletal rearrangements during growth cone guidance . Cell. 83:1995;171-176.
8. Nakanishi H., Obaishi H., Satoh A., et al. Neurabin A novel neural tissue-specific actin filament-binding protein involved in neurite formation . J Cell Biol. 139:1997;951-961.
9. van Rossum D., Hanisch U.K. Cytoskeletal dynamics in dendritic spines Direct modulation by glutamate receptors? Trends Neurosci. 22:1999;290-295.
10. Mackay D.J., Nobes C.D., Hall A. The Rho's progress A potential role during neuritogenesis for the Rho family of GTPases . Trends Neurosci. 18:1995;496-501.
11. Luo L., Jan L., Jan Y.N. Small GTPases in axon outgrowth. Perspect Dev Neurobiol. 4:1996;199-204.
12. Luo L., Jan L.Y., Jan Y.N. Rho family GTP-binding proteins in growth cone signalling. Curr Opin Neurobiol. 7:1997;81-86.
13. Luo L. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci. 1:2000;173-180.
14. van Veen M.P., van Pelt J. Dynamic mechanisms of neuronal outgrowth. Prog Brain Res. 102:1994;95-108.
15. Lin C.H., Thompson C.A., Forscher P. Cytoskeletal reorganization underlying growth cone motility. Curr Opin Neurobiol. 4:1994;640-647.
16. O'Connor T.P., Duerr J.S., Bentley D. Pioneer growth cone steering decisions mediated by single filopodial contacts in situ. J Neurosci. 10:1990;3935-3946.
17. Sobue K., Kanda K. Alpha-actinins, calspectin (brain spectrin or fodrin), and actin participate in adhesion and movement of growth cones. Neuron. 3:1989;311-319.
18. Wahl S., Barth H., Ciossek T., et al. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J Cell Biol. 149:2000;263-270.
19. Dickson B.J. Rho GTPases in growth cone guidance. Curr Opin Neurobiol. 11:2001;103-110.
20. Ozdinler P.H., Erzurumlu R.S. Regulation of neurotrophin-induced axonal responses via Rho GTPases. J Comp Neurol. 438:2001;377-387.
21. Ramakers G.J. Rho proteins and the cellular mechanisms of mental retardation. Am J Med Genet. 94:2000;367-371.
22. Kozma R., Sarner S., Ahmed S., et al. Rho family GTPases and neuronal growth cone remodelling Relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid . Mol Cell Biol. 17:1997;1201-1211.
23. Li Z., Van Aelst L., Cline H.T. Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo. Nat Neurosci. 3:2000;217-225.
24. Wong W.T., Faulkner-Jones B.E., Sanes J.R., et al. Rapid dendritic remodeling in the developing retina Dependence on neurotransmission and reciprocal regulation by Rac and Rho . J Neurosci. 20:2000;5024-5036.
25. Li X., Saint-Cyr-Proulx E., Aktories K., et al. Rac1 and Cdc42 but not RhoA or Rho kinase activities are required for neurite outgrowth induced by the Netrin-1 receptor DCC (deleted in colorectal cancer) in N1E-115 neuroblastoma cells. J Biol Chem. 277:2002;15207-15214.
26. Threadgill R., Bobb K., Ghosh A. Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42. Neuron. 19:1997;625-634.
27. Matus A., Brinkhaus H., Wagner U. Actin dynamics in dendritic spines A form of regulated plasticity at excitatory synapses . Hippocampus. 10:2000;555-560.
28. Calverley R.K., Jones D.G. Contributions of dendritic spines and perforated synapses to synaptic plasticity. Brain Res Brain Res Rev. 15:1990;215-249.
29. Matus A. Postsynaptic actin and neuronal plasticity. Curr Opin Neurobiol. 9:1999;561-565.
30. Matus A. Actin-based plasticity in dendritic spines. Science. 290:2000;754-758.
31. Allen K.M., Gleeson J.G., Bagrodia S., et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet. 20:1998;25-30.
32. Bienvenu T., des Portes V., McDonell N., et al. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet. 93:2000;294-298.
33. Billuart P., Chelly J., Carrie A., et al. Determination of the gene structure of human oligophrenin-1 and identification of three novel polymorphisms by screening of DNA from 164 patients with non-specific X-linked mental retardation. Ann Genet. 43:2000;5-9.
34. Kutsche K., Yntema H., Brandt A., et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat Genet. 26:2000;247-250.
35. Huttenlocher P.R. Dendritic development in neocortex of children with mental defect and infantile spasms. Neurology. 24:1974;203-210.
36. Purpura D.P. Dendritic spine "dysgenesis" and mental retardation. Science. 186:1974;1126-1128.
37. Marin-Padilla M. Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome A Golgi study . J Comp Neurol. 167:1976;63-81.
38. Rudelli R.D., Brown W.T., Wisniewski K., et al. Adult fragile X syndrome Clinico-neuropathologic findings . Acta Neuropathol. 67:1985;289-295.
39. Ferrer I., Galofre E. Dendritic spine anomalies in fetal alcohol syndrome. Neuropediatrics. 18:1987;161-163.
40. Ferrer I., Gullotta F. Down's syndrome and Alzheimer's disease dendritic spine counts in the hippocampus . Acta Neuropathol. 79:1990;680-685.
41. Hinton V.J., Brown W.T., Wisniewski K., et al. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet. 41:1991;289-294.
42. Marin-Padilla M. Structural abnormalities of the cerebral cortex in human chromosomal aberrations A Golgi study . Brain Res. 44:1972;625-629.
43. Comery T.A., Harris J.B., Willems P.J., et al. Abnormal dendritic spines in fragile X knockout mice maturation and pruning deficits . Proc Natl Acad Sci U S A. 94:1997;5401-5404.
44. Irwin S.A., Patel B., Idupulapati M., et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome A quantitative examination . Am J Med Genet. 98:2001;161-167.
45. Nimchinsky E.A., Oberlander A.M., Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci. 21:2001;5139-5146.
46. Bienvenu T., des Portes V., Saint Martin A., et al. Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. Hum Mol Genet. 7:1998;1311-1315.
47. D'Adamo P., Menegon A., Lo Nigro C., et al. Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet. 19:1998;134-139.
48. Geppert M., Goda Y., Stevens C.F., et al. The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion. Nature. 387:1997;810-814.
49. Ishizaki H., Miyoshi J., Kamiya H., et al. Role of rab GDP dissociation inhibitor alpha in regulating plasticity of hippocampal neurotransmission. Proc Natl Acad Sci U S A. 97:2000;11587-11592.
50. Vervoort V.S., Beachem M.A., Edwards P.S., et al. AGTR2 mutations in X-linked mental retardation. Science. 296:2002;2401-2403.
51. Bienvenu T., Poirier K., Friocourt G., et al. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet. 11:2002;981-991.
52. Meloni I., Muscettola M., Raynaud M., et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet. 30:2002;436-440.
53. Gu Y., Shen Y., Gibbs R.A., et al. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet. 13:1996;109-113.
54. Gecz J., Gedeon A.K., Sutherland G.R., et al. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet. 13:1996;105-108.
55. Miller W.J., Skinner J.A., Foss G.S., et al. Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain. Eur J Neurosci. 12:2000;381-384.
56. Carrie A., Jun L., Bienvenu T., et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet. 23:1999;25-31.
57. Zemni R., Bienvenu T., Vinet M.C., et al. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet. 24:2000;167-170.
58. Fukami M., Kirsch S., Schiller S., et al. A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation. Am J Hum Genet. 67:2000;563-573.
59. Gibbons R.J., Picketts D.J., Villard L., et al. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 80:1995;837-845.
60. Gibbons R.J., Higgs D.R. Molecular-clinical spectrum of the ATR-X syndrome. Am J Med Genet. 97:2000;204-212.
61. Villard L., Toutain A., Lossi A.M., et al. Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia. Am J Hum Genet. 58:1996;499-505.
62. Amir R.E., Van den Veyver I.B., Wan M., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 23:1999;185-188.
63. Couvert P., Bienvenu T., Aquaviva C., et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 10:2001;941-946.
64. Trivier E., De Cesare D., Jacquot S., et al. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature. 384:1996;567-570.
65. Merienne K., Jacquot S., Pannetier S., et al. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat Genet. 22:1999;13-14.
66. Takashima S., Iida K., Mito T., et al. Dendritic and histochemical development and ageing in patients with Down's syndrome. J Intellect Disabil Res. 38:1994;265-273.
67. Bauman M.L., Kemper T.L. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol. 58:1982;55-63.
68. Belichenko P.V., Oldfors A., Hagberg B., et al. Rett syndrome 3-D confocal microscopy of cortical pyramidal dendrites and afferents . Neuroreport. 5:1994;1509-1513.
69. Capone G.T. Drugs that increase intelligence Application for childhood cognitive impairment . MRDD Res Rev. 4:1998;36-49.